What is Jasper Therapeutics Inc. Common Stock's current stock price?

Jasper Therapeutics Inc. Common Stock (JSPR) currently trades at USD 0.6027. Track real-time price changes and historical performance on AllInvestView.

What sector is Jasper Therapeutics Inc. Common Stock in?

Jasper Therapeutics Inc. Common Stock operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Jasper Therapeutics Inc. Common Stock JSPR · Stock Open Jasper Therapeutics Inc. Common Stock in new tab

0.6027 USD

Add to portfolio

EPS

-0.93

P/B

12.36

ROE

-255.05

Beta

3.04

Target Price

7.38 USD

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Jasper Therapeutics Inc. Common Stock (JSPR)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Jasper Therapeutics Inc. Common Stock Analysis (JSPR)

United States Health Care Official Website Stock

Is Jasper Therapeutics Inc. Common Stock a good investment? Jasper Therapeutics Inc. Common Stock (JSPR) is currently trading at 0.6027 USD. Market analysts have a consensus price target of 7.38 USD. This suggests a potential upside from current levels.

Earnings Schedule: Jasper Therapeutics Inc. Common Stock is expected to release its next earnings report on Nov. 9, 2026. The market consensus estimate for Forward EPS is -2.56.

Investor FAQ

Does Jasper Therapeutics Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Jasper Therapeutics Inc. Common Stock?

Jasper Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 9, 2026. The company currently has a trailing EPS of -0.93.

Company Profile

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of biologic agents to enhance the outcomes in patients with immunologically-driven disorders. The company is based in Redwood City, California.

Exchange Ticker

NMS (United States) JSPR

Trades

Dividend History paid per year (USD)

No dividend history available.

Stock Splits

Split Date	Split Ratio to 1
Jan. 4, 2024	1:10

Jasper Therapeutics Inc. Common Stock JSPR · Stock Open Jasper Therapeutics Inc. Common Stock in new tab

Key Metrics

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Jasper Therapeutics Inc. Common Stock Analysis (JSPR)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Jasper Therapeutics Inc. Common Stock JSPR · Stock Open Jasper Therapeutics Inc. Common Stock in new tab

Key Metrics

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Jasper Therapeutics Inc. Common Stock Analysis (JSPR)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications